MARKET ACCESS AND PATIENT ACTIVATION (MAPA)

Giving Patients
Better Access To Innovative treatments

We believe that we can unlock maximal value working as your trusted strategic partner, supporting you at every step of your market access and patient activation journey, from strategy to delivery.

Working with a single team that become experts in your asset leads to efficiency, cost-effectiveness, and connectivity that can otherwise be lost when working with multiple partners.

Making Market Access Real

Keep up to date on the latest topics, discussions and key industry insights from our IQVIA MAPA team.

Launch Excellence: Driving Access and Innovation in the NHS

This session focuses on how pharmaceutical companies can better align with the NHS to ensure successful product launches. It introduces the three core pillars of Launch Excellence.

Accelerating innovation across the health system

In this episode, we are joined by Richard Stubbs, Chair of the National Health Innovation Network and Kate Woolland, Chief Operating Officer, Closed Loop Medicine to discuss the adoption of accelerating innovation and how we can cross-collaborate for better patient outcomes.

Navigating Rare Disease Policy Landscape

The shift from sickness to prevention, especially in the context of early diagnosis and treatment, can have a significant impact on patients, families, and healthcare systems. As we navigate these changes, it's crucial that rare diseases are not forgotten and are included in the broader healthcare discussions. Looking forward to seeing how we can continue to advocate for rare diseases in the evolving healthcare landscape.

Related Solutions

Contact Us